$4.63
-0.34-6.94%
最終更新: Oct 8, 6:58 AM
Benzinga
Benzinga
Benzinga
火曜日, 10 27
Benzinga
© 2026 Benzinga | All Rights Reserved
CNS Pharmaceuticals (CNSP) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.24 | $-5.37 | $-5.37 | $-6.63 |
| Actual | $-0.38 | $-7.30 | $-10.15 | $-5.76 |
| Surprise | -58.3% | -35.9% | -89.0% | +13.1% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.27 | $-0.27 |
| Revenue | ||
| Consensus | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-0.38 | $-0.24 | -58.3 % |
| Q1 | May 14, 2026 | $-7.30 | $-5.37 | -35.9 % |
| Q4 | Mar 31, 2026 | $-10.15 | $-5.37 | -89.0 % |
| Q3 | Nov 17, 2025 | $-5.76 | $-6.63 | 13.1 % |